M1A.2520 Drug-induced chronic gout, left hip, without tophus (tophi)

Name of the Condition

• Drug-Induced Chronic Gout, Left Hip, Without Tophus (tophi)

Summary

Drug-induced chronic gout, left hip, without tophus is a form of arthritis affecting the left hip joint, resulting from prolonged elevated uric acid levels due to medication use. It leads to recurrent joint inflammation and potential tissue damage, characterized by persistent symptoms without the formation of tophi (urate crystal deposits) in this stage.

Causes

This condition arises from medications that interfere with uric acid metabolism or excretion, causing accumulation in the blood. Over time, urate crystals deposit in the left hip joint and surrounding tissues, triggering inflammation. Common culprits include diuretics, low-dose aspirin, and certain chemotherapy agents.

Risk Factors

• Use of medications that increase uric acid levels (e.g., diuretics, low-dose aspirin)
• Prolonged exposure to urate-raising drugs
• Pre-existing hyperuricemia or gout history
• Renal impairment affecting drug clearance

Symptoms

• Recurrent episodes of intense left hip pain, often with swelling and redness
• Persistent warmth and tenderness in the affected hip
• Stiffness and limited range of motion in the left hip
• Flare-ups triggered by stress, diet, or illness

Diagnosis

Diagnosis involves clinical evaluation, laboratory tests, and imaging. Blood tests assess uric acid levels, while joint fluid analysis may detect urate crystals. Imaging, such as X-rays or ultrasound, evaluates joint damage and rules out other conditions. The absence of tophi is confirmed clinically or via imaging.

Treatment Options

Treatment focuses on reducing uric acid levels and managing symptoms. Medications like urate-lowering agents (e.g., allopurinol) are used long-term. Anti-inflammatory drugs (NSAIDs, colchicine) address acute flare-ups. Lifestyle modifications, including dietary changes and hydration, support management.

Prognosis and Follow-Up

With proper treatment, symptoms can be controlled, and joint damage may be minimized. Regular follow-up monitors uric acid levels and treatment efficacy. Untreated cases may progress to chronic arthritis or tophus formation.

Complications

Untreated or poorly managed cases may lead to joint deformity, chronic pain, or reduced mobility. Persistent inflammation can damage cartilage and bone over time.

Lifestyle & Prevention

• Avoid medications known to raise uric acid when possible.
• Maintain a balanced diet low in purines (e.g., limit red meat, alcohol).
• Stay hydrated to support uric acid excretion.
• Follow prescribed treatment plans consistently.

When to Seek Professional Help

Seek care if experiencing severe or worsening left hip pain, swelling, or stiffness. Prompt evaluation is needed for persistent symptoms or flare-ups unresponsive to home management.

Tips for Medical Coders

Document the left hip involvement and absence of tophi clearly. Ensure medication history and clinical findings supporting drug-induced gout are recorded. Code M1A.2520 is specific to the left hip without tophus; verify laterality and tophus status match documentation.